These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 17898154)

  • 61. In vitro-in vivo correlation for drugs and other compounds eliminated by glucuronidation in humans: pitfalls and promises.
    Miners JO; Knights KM; Houston JB; Mackenzie PI
    Biochem Pharmacol; 2006 May; 71(11):1531-9. PubMed ID: 16455060
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Evidence for regulation of UDP-glucuronosyltransferase (UGT) 1A1 protein expression and activity via DNA methylation in healthy human livers.
    Yasar U; Greenblatt DJ; Guillemette C; Court MH
    J Pharm Pharmacol; 2013 Jun; 65(6):874-83. PubMed ID: 23647681
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Human UDP-glucuronosyltransferase 1A1 is the primary enzyme responsible for the N-glucuronidation of N-hydroxy-PhIP in vitro.
    Malfatti MA; Felton JS
    Chem Res Toxicol; 2004 Aug; 17(8):1137-44. PubMed ID: 15310245
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Glucuronidation of 7-ethyl-10-hydroxycamptothecin (SN-38), an active metabolite of irinotecan (CPT-11), by human UGT1A1 variants, G71R, P229Q, and Y486D.
    Jinno H; Tanaka-Kagawa T; Hanioka N; Saeki M; Ishida S; Nishimura T; Ando M; Saito Y; Ozawa S; Sawada J
    Drug Metab Dispos; 2003 Jan; 31(1):108-13. PubMed ID: 12485959
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Altered AZT (3'-azido-3'-deoxythymidine) glucuronidation kinetics in liver microsomes as an explanation for underprediction of in vivo clearance: comparison to hepatocytes and effect of incubation environment.
    Engtrakul JJ; Foti RS; Strelevitz TJ; Fisher MB
    Drug Metab Dispos; 2005 Nov; 33(11):1621-7. PubMed ID: 16049128
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The human UDP-glucuronosyltransferase UGT1A3 is highly selective towards N2 in the tetrazole ring of losartan, candesartan, and zolarsartan.
    Alonen A; Finel M; Kostiainen R
    Biochem Pharmacol; 2008 Sep; 76(6):763-72. PubMed ID: 18674515
    [TBL] [Abstract][Full Text] [Related]  

  • 67. In vitro inhibitory effects of non-steroidal antiinflammatory drugs on UDP-glucuronosyltransferase 1A1-catalysed estradiol 3beta-glucuronidation in human liver microsomes.
    Mano Y; Usui T; Kamimura H
    Biopharm Drug Dispos; 2005 Jan; 26(1):35-9. PubMed ID: 15593333
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Quantitative prediction of human intestinal glucuronidation effects on intestinal availability of UDP-glucuronosyltransferase substrates using in vitro data.
    Nakamori F; Naritomi Y; Hosoya K; Moriguchi H; Tetsuka K; Furukawa T; Kadono K; Yamano K; Terashita S; Teramura T
    Drug Metab Dispos; 2012 Sep; 40(9):1771-7. PubMed ID: 22685216
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Regio- and stereospecific N-glucuronidation of medetomidine: the differences between UDP glucuronosyltransferase (UGT) 1A4 and UGT2B10 account for the complex kinetics of human liver microsomes.
    Kaivosaari S; Toivonen P; Aitio O; Sipilä J; Koskinen M; Salonen JS; Finel M
    Drug Metab Dispos; 2008 Aug; 36(8):1529-37. PubMed ID: 18474681
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Intestinal UDP-Glucuronosyltransferase 1A1 and Protection against Irinotecan-Induced Toxicity in a Novel UDP-Glucuronosyltransferase 1A1 Tissue-Specific Humanized Mouse Model.
    Mennillo E; Yang X; Weber AA; Maruo Y; Verreault M; Barbier O; Chen S; Tukey RH
    Drug Metab Dispos; 2022 Jan; 50(1):33-42. PubMed ID: 34697081
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Accurate identification of UDP-glucuronosyltransferase 1A1 (UGT1A1) inhibitors using UGT1A1-overexpressing HeLa cells.
    Sun H; Zhou X; Wu B
    Xenobiotica; 2015; 45(11):945-53. PubMed ID: 26068529
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Role of cysteine residues in the function of human UDP glucuronosyltransferase isoform 1A1 (UGT1A1).
    Ghosh SS; Lu Y; Lee SW; Wang X; Guha C; Roy-Chowdhury J; Roy-Chowdhury N
    Biochem J; 2005 Dec; 392(Pt 3):685-92. PubMed ID: 16171463
    [TBL] [Abstract][Full Text] [Related]  

  • 73. cDNA cloning and functional analysis of minipig uridine diphosphate-glucuronosyltransferase 1A1.
    Miyake Y; Mayumi K; Jinno H; Tanaka-Kagawa T; Narimatsu S; Hanioka N
    Biol Pharm Bull; 2013; 36(3):452-61. PubMed ID: 23449330
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Absolute quantification of UGT1A1 in various tissues and cell lines using isotope label-free UPLC-MS/MS method determines its turnover number and correlates with its glucuronidation activities.
    Xu B; Gao S; Wu B; Yin T; Hu M
    J Pharm Biomed Anal; 2014 Jan; 88():180-90. PubMed ID: 24055854
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Effect of the acute phase response induced by endotoxin administration on the expression and activity of UGT isoforms in rats.
    Alkharfy KM; Poloyac SM; Congiu M; Desmond PV; Frye RF
    Drug Metab Lett; 2008 Dec; 2(4):248-55. PubMed ID: 19356101
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Quantitation of UGT1A1 in human liver microsomes using stable isotope-labelled peptides and mass spectrometry based proteomic approaches.
    Sridar C; Hanna I; Hollenberg PF
    Xenobiotica; 2013 Apr; 43(4):336-45. PubMed ID: 22943130
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Using human recombinant UDP-glucuronosyltransferase isoforms and a relative activity factor approach to model total body clearance of laropiprant (MK-0524) in humans.
    Gibson CR; Lu P; Maciolek C; Wudarski C; Barter Z; Rowland-Yeo K; Stroh M; Lai E; Nicoll-Griffith DA
    Xenobiotica; 2013 Dec; 43(12):1027-36. PubMed ID: 23641955
    [TBL] [Abstract][Full Text] [Related]  

  • 78. An optimized ratiometric fluorescent probe for sensing human UDP-glucuronosyltransferase 1A1 and its biological applications.
    Lv X; Ge GB; Feng L; Troberg J; Hu LH; Hou J; Cheng HL; Wang P; Liu ZM; Finel M; Cui JN; Yang L
    Biosens Bioelectron; 2015 Oct; 72():261-7. PubMed ID: 25988789
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Differences in the glucuronidation of resveratrol and pterostilbene: altered enzyme specificity and potential gender differences.
    Dellinger RW; Garcia AM; Meyskens FL
    Drug Metab Pharmacokinet; 2014; 29(2):112-9. PubMed ID: 23965644
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Glucuronidation of acetaminophen is independent of UGT1A1 promotor genotype.
    Rauchschwalbe SK; Zühlsdorf MT; Wensing G; Kuhlmann J
    Int J Clin Pharmacol Ther; 2004 Feb; 42(2):73-7. PubMed ID: 15180166
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.